pazopanib
NDC 82293-022, pazopanib hydrochloride, tablet, film coated, from Novugen Pharma (USA) LLC..
- Product NDC
- 82293-022
- Status
- Listed
- Labeler
- Novugen Pharma (USA) LLC.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218231
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82293-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PAZOPANIB HYDROCHLORIDE200 mg/1
Pharmacologic classes
Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82293-022-10 | 82293002210 | 120 TABLET, FILM COATED in 1 BOTTLE (82293-022-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/25305d33-caa0-4577-8b7b-06e430c34c39
Use it
Look up 82293-022 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82293-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82293-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.